查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424066

先進醫療製藥(ATMP)CDMO市場、份額、規模、趨勢、行業分析報告：按產品、階段、適應症、地區、細分市場預測，2024-2032年

Advanced Therapy Medicinal Products CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others); By Phase; By Indication; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到 2032 年，全球先進醫療製藥 (ATMP) CDMO 市場規模預計將達到 262.7 億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

隨著人群中多種疾病的發展，慢性健康問題現在可以用普通藥物治療，研究人員和政府機構被迫投資於遺傳醫學以及細胞和組織療法。 這種持續的趨勢為製藥公司創新新療法創造了有利的環境，並推動了對擁有必要基礎設施來開發、測試和製造新療法的組織的需求。我們需要合約組織（CDMO）的支持。

政府監管製藥業的舉措不斷增多，對先進醫療製藥 (ATMP) CDMO 市場的成長機會產生了積極影響。 2023 年 9 月，英國 CDMO Rentschler Biopharma SE 獲得藥品和保健品監管機構的批准，可以開發和供應用於生物加工和基因治療（包括 cGMP 生產）的腺相關病毒載體（AAV）。

旨在擴大治療健康問題的研發活動的策略合作和夥伴關係的新興市場正在對 ATMP CDMO 市場產生積極影響。 Reprocell 將與 Histocell 合作生產源自間質幹細胞的先進療法和藥物。

細胞治療和基因治療生產顯示出積極的市場前景。 根據《基因、細胞和RNA治療格局報告》，2023年第三季度，有27種基因療法、26種RNA療法和65種非基因改造細胞療法被批准用於臨床。 第三季處於1期臨床試驗的基因治療藥物總數較第一季成長7%。 這一趨勢顯示了對先進醫療藥物生產的潛在需求，從而增加了未來幾年對 CDMO 的需求。

組織工程產業在市場上勢頭強勁。 其驅動力在於其在組織替換、修復和再生方面的深入影響，用於治療與皮膚、心臟、肝臟和肺組織相關的健康問題。 與組織工程治療開發相關的研究活動的增加預計將推動先進療法的 CDMO 市場。

先進醫療藥品 (ATMP) CDMO 市場報告亮點

由於與基因治療相關的臨床試驗的增加，預計基因治療領域在未來幾年將有最高的成長。

由於治療開發數量的增加，第一期市場佔據了最大的收入份額。

由於癌症患者數量增加且形式多樣，腫瘤領域所佔份額最大。

由於細胞和基因療法投資的增加，預計亞太地區將在預測期內實現最快的成長。

目錄

第 1 章簡介

第 2 章執行摘要

第 3 章研究方法

第 4 章全球先進醫療藥品 (ATMP) CDMO 市場洞察

  • 先進醫療藥品 (ATMP) CDMO 市場 - 階段快照
  • 先進醫療藥品 (ATMP) CDMO 市場動態
    • 促進因素和機會
      • 生物技術中基於細胞和基因的療法的興起
      • CDMO產能高
    • 抑制因素和挑戰
      • ATMP 生產相關的技能短缺可能會阻礙市場成長
  • PESTEL 分析
  • 先進醫藥CDMO市場階段趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第 5 章按適應症劃分的全球先進醫療製藥 (ATMP) CDMO 市場

  • 主要發現
  • 簡介
  • 腫瘤學
  • 心臟病學
  • 中樞神經系統
  • 肌肉骨骼系統
  • 傳染病
  • 皮膚科
  • 內分泌、新陳代謝、遺傳學
  • 免疫學和炎症
  • 眼科
  • 血液學
  • 胃腸病學
  • 其他

第 6 章按產品劃分的全球先進醫療製藥 (ATMP) CDMO 市場

  • 主要發現
  • 簡介
  • 細胞療法
  • 基因治療

第 7 章全球先進醫療製藥 (ATMP) CDMO 市場（按階段）

  • 主要發現
  • 簡介
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第 8 章按地區劃分的全球先進醫療藥品 (ATMP) CDMO 市場

  • 主要發現
  • 簡介
    • 2019-2032 年先進醫療藥品 (ATMP) CDMO 市場評估（按地區）
  • 先進醫療藥品 (ATMP) CDMO 市場 - 北美
    • 北美：先進醫療製藥 (ATMP) CDMO 市場，按適應症劃分，2019-2032 年
    • 北美：2019-2032 年先進醫療製藥 (ATMP) CDMO 市場（按階段）
    • 北美：先進醫療製藥 (ATMP) CDMO 市場（按產品），2019-2032 年
    • 先進醫療藥品 (ATMP) CDMO 市場 - 美國
    • 先進醫療藥品 (ATMP) CDMO 市場 - 加拿大
  • 先進醫療藥品 (ATMP) CDMO 市場 - 歐洲
    • 歐洲：2019-2032 年先進醫療製藥 (ATMP) CDMO 市場（按適應症）
    • 歐洲：2019-2032 年先進醫療製藥 (ATMP) CDMO 市場（按階段）
    • 歐洲：先進醫療製藥 (ATMP) CDMO 市場（按產品），2019-2032 年
    • 先進醫療藥品 (ATMP) CDMO 市場 - 英國
    • 先進醫療藥品 (ATMP) CDMO 市場 - 法國
    • 先進醫療藥品 (ATMP) CDMO 市場 - 德國
    • 先進醫療藥品 (ATMP) CDMO 市場 - 義大利
    • 先進醫療藥品 (ATMP) CDMO 市場 - 西班牙
    • 先進醫療藥品 (ATMP) CDMO 市場 - 荷蘭
    • 先進醫療藥品 (ATMP) CDMO 市場 - 俄羅斯
  • 先進醫療藥品 (ATMP) CDMO 市場 - 亞太地區
    • 亞太地區：2019-2032 年先進醫療製藥 (ATMP) CDMO 市場（按適應症）
    • 亞太地區：2019-2032 年先進醫療製藥 (ATMP) CDMO 市場（按階段）
    • 亞太地區：2019-2032 年先進醫療製藥 (ATMP) CDMO 市場（按產品）
    • 先進醫療藥品 (ATMP) CDMO 市場 - 中國
    • 先進醫療藥品 (ATMP) CDMO 市場 - 印度
    • 先進醫療藥品 (ATMP) CDMO 市場 - 馬來西亞
    • 先進醫療用藥 CDMO 市場 - 日本
    • 先進醫療藥品 (ATMP) CDMO 市場 - 印尼
    • 先進醫療藥品 (ATMP) CDMO 市場 - 韓國
  • 先進醫療藥品 (ATMP) CDMO 市場 - 中東和非洲
    • 中東和非洲：先進醫療藥品 (ATMP) CDMO 市場，按適應症劃分，2019-2032 年
    • 中東和非洲：2019-2032 年先進醫療藥品 (ATMP) CDMO 市場（按階段）
    • 中東和非洲：先進醫療製藥 (ATMP) CDMO 市場（按產品），2019-2032 年
    • 先進醫療藥品 (ATMP) CDMO 市場 - 沙烏地阿拉伯
    • 先進醫療藥品 (ATMP) CDMO 市場 - 阿拉伯聯合大公國
    • 先進醫療藥品 (ATMP) CDMO 市場 - 以色列
    • 先進醫療藥品 (ATMP) CDMO 市場 - 南非
  • 先進醫療藥品 (ATMP) CDMO 市場 - 拉丁美洲
    • 拉丁美洲：先進醫療製藥 (ATMP) CDMO 市場，按適應症劃分，2019-2032 年
    • 拉丁美洲：2019-2032 年先進醫療藥品 (ATMP) CDMO 市場（按階段）
    • 拉丁美洲：先進醫療製藥 (ATMP) CDMO 市場（按產品），2019-2032 年
    • 先進醫療藥品 (ATMP) CDMO 市場 - 墨西哥
    • 先進醫療藥品 (ATMP) CDMO 市場 - 巴西
    • 先進醫療藥品 (ATMP) CDMO 市場 - 阿根廷

第 9 章競爭態勢

  • 擴張與收購分析
    • 擴大
    • 收購
  • 夥伴關係/協作/協議/揭露

第 10 章公司簡介

  • AGC Biologics（Switzerland）
  • Bio Elpida（France）
  • BlueReg（France）
  • Catalent（US）
  • Celonic（Switzerland）
  • CGT Catapult（UK）
  • Lonza（Switzerland）
  • Medicine Patheon（US）
  • Minaris Regenerative（US）
  • Rentschler Biopharma SE（US）
  • WuXi Advanced Therapies（US）
Product Code: PM4326

The global advanced therapy medicinal products CDMO market size is expected to reach USD 26.27 billion by 2032, according to a new study by Polaris Market Research. The report "Advanced Therapy Medicinal Products CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others); By Phase; By Indication; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The evolution of numerous diseases among the population and the ability to cure chronic health issues with the prevailing medicines is compelling researchers and government institutions to invest in genetic medicine and cell and tissue therapies. This ongoing trend is facilitating a compatible environment for pharmaceutical companies to innovate new therapies, driving the need for organizations that have the required infrastructure for the development, testing, and manufacturing of new therapies, necessitating the assistance of contract development and manufacturing organizations (CDMO).

The rising government initiatives to regulate the pharmaceutical industry are showing a positive impact on the advanced therapy medicinal products CDMO market growth opportunities. In September 2023, UK CDMO Rentschler Biopharma SE received approval to develop and supply adeno-associated virus vectors (AAV) for gene therapy, including bioprocessing and cGMP production, from the Medicines & Healthcare Products Regulatory Agency.

The growing strategic collaborations and partnerships to expand the research and development activities towards treating health problems are positively influencing the ATMP CDMO market. With the Histocell partnership, Reprocell will produce advanced therapies and medicinal products generated from mesenchymal stem cells.

Cell and gene therapy production is showing a positive outlook in the market. According to the Gene, Cell, & RNA Therapy Landscape Report, in Q3 2023, 27 gene therapies, 26 RNA therapies, and 65 non-genetically modified cell therapies, received approval for clinical use. The total number of gene therapies in phase 1 Q3 registered growth by 7% compared to Q1. This trend is demonstrating the potential demand to produce advanced therapeutic medicinal products, boosting the need for CDMO in the coming years.

The tissue engineering industry is gaining momentum in the marketplace, driven by its profound scope in the replacement, repair, and regeneration of tissues, which are used to cure skin, heart, liver, and lung tissue-related health problems. The rising research activities on the development of tissue engineering therapies are expected to drive the advanced therapy medicinal products CDMO market.

Advanced Therapy Medicinal Products CDMO Market Report Highlights

Gene therapy segment is anticipated to witness the highest growth in the coming years due to the increasing clinical trials on gene therapies.

Phase I segment accounted for the largest revenue share, owing to the rise in number of therapeutic developments.

Oncology segment held the largest share, due to the rising number of cancer patients and its varied forms

Asia pacific is projected to register the fastest growth during the forecast period, attributable to the growing investments in cell and gene therapies.

The global players include AGC Biologics, Bio Elpida, BlueReg, Catalent, Celonic, CGT Catapult, Lonza, Medicine Patheon, & Minaris Regenerative.

Polaris Market Research has segmented the advanced therapy medicinal products CDMO market report based on product, phase, indication and region:

Advanced Therapy Medicinal Products CDMO, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Cell Therapy
  • Gene Therapy

Advanced Therapy Medicinal Products CDMO, Phase Outlook (Revenue - USD Billion, 2019 - 2032)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Advanced Therapy Medicinal Products CDMO, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oncology
  • Cardiology
  • Central nervous system
  • Musculoskeletal
  • Infectious disease
  • Dermatology
  • Endocrine, metabolic, genetic
  • Immunology & inflammation
  • Ophthalmology
  • Hematology
  • Gastroenterology
  • Others

Advanced Therapy Medicinal Products CDMO, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Advanced Therapy Medicinal Products CDMO Market Insights

  • 4.1. Advanced Therapy Medicinal Products CDMO Market - Phase Snapshot
  • 4.2. Advanced Therapy Medicinal Products CDMO Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The rising cell and gene-based therapies in biotechnology
      • 4.2.1.2. The higher production capability of CDMOs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The talent shortage pertaining to ATMP production is likely to impede market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Advanced Therapy Medicinal Products CDMO Market Phase Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Advanced Therapy Medicinal Products CDMO Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • 5.3. Oncology
    • 5.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 5.4. Cardiology
    • 5.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Cardiology, by Region, 2019-2032 (USD Billion)
  • 5.5. Central nervous system
    • 5.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Central nervous system, by Region, 2019-2032 (USD Billion)
  • 5.6. Musculoskeletal
    • 5.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Musculoskeletal, by Region, 2019-2032 (USD Billion)
  • 5.7. Infectious disease
    • 5.7.1. Global Advanced Therapy Medicinal Products CDMO Market, by Infectious disease, by Region, 2019-2032 (USD Billion)
  • 5.8. Dermatology
    • 5.8.1. Global Advanced Therapy Medicinal Products CDMO Market, by Dermatology, by Region, 2019-2032 (USD Billion)
  • 5.3. Endocrine, metabolic, genetic
    • 5.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Endocrine, metabolic, genetic, by Region, 2019-2032 (USD Billion)
  • 5.4. Immunology & inflammation
    • 5.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Immunology & inflammation, by Region, 2019-2032 (USD Billion)
  • 5.5. Ophthalmology
    • 5.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Ophthalmology, by Region, 2019-2032 (USD Billion)
  • 5.6. Hematology
    • 5.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Hematology, by Region, 2019-2032 (USD Billion)
  • 5.7. Gastroenterology
    • 5.7.1. Global Advanced Therapy Medicinal Products CDMO Market, by Gastroenterology, by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Advanced Therapy Medicinal Products CDMO Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Advanced Therapy Medicinal Products CDMO Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Cell Therapy
    • 6.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Cell Therapy, by Region, 2019-2032 (USD Billion)
  • 6.4. Gene Therapy
    • 6.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Gene Therapy, by Region, 2019-2032 (USD Billion)

7. Global Advanced Therapy Medicinal Products CDMO Market, by Phase

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • 7.3. Phase I
    • 7.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase I, By Region, 2019-2032 (USD Billion)
  • 7.4. Phase II
    • 7.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase II, By Region, 2019-2032 (USD Billion)
  • 7.5. Phase III
    • 7.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase III, By Region, 2019-2032 (USD Billion)
  • 7.6. Phase IV
    • 7.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase IV, By Region, 2019-2032 (USD Billion)

8. Global Advanced Therapy Medicinal Products CDMO Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Advanced Therapy Medicinal Products CDMO Market - North America
    • 8.3.1. North America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.3.2. North America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.3.3. North America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Advanced Therapy Medicinal Products CDMO Market - U.S.
      • 8.3.4.1. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Advanced Therapy Medicinal Products CDMO Market - Canada
      • 8.3.5.1. Canada: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Advanced Therapy Medicinal Products CDMO Market - Europe
    • 8.4.1. Europe: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Advanced Therapy Medicinal Products CDMO Market - UK
      • 8.4.4.1. UK: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Advanced Therapy Medicinal Products CDMO Market - France
      • 8.4.5.1. France: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Advanced Therapy Medicinal Products CDMO Market - Germany
      • 8.4.6.1. Germany: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Advanced Therapy Medicinal Products CDMO Market - Italy
      • 8.4.7.1. Italy: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Advanced Therapy Medicinal Products CDMO Market - Spain
      • 8.4.8.1. Spain: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Advanced Therapy Medicinal Products CDMO Market - Netherlands
      • 8.4.9.1. Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Advanced Therapy Medicinal Products CDMO Market - Russia
      • 8.4.10.1. Russia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Advanced Therapy Medicinal Products CDMO Market - Asia Pacific
    • 8.5.1. Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Advanced Therapy Medicinal Products CDMO Market - China
      • 8.5.4.1. China: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Advanced Therapy Medicinal Products CDMO Market - India
      • 8.5.5.1. India: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Advanced Therapy Medicinal Products CDMO Market - Malaysia
      • 8.5.6.1. Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Advanced Therapy Medicinal Products CDMO Market - Japan
      • 8.5.7.1. Japan: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Advanced Therapy Medicinal Products CDMO Market - Indonesia
      • 8.5.8.1. Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Advanced Therapy Medicinal Products CDMO Market - South Korea
      • 8.5.9.1. South Korea: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Advanced Therapy Medicinal Products CDMO Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Advanced Therapy Medicinal Products CDMO Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Advanced Therapy Medicinal Products CDMO Market - UAE
      • 8.6.5.1. UAE: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Advanced Therapy Medicinal Products CDMO Market - Israel
      • 8.6.6.1. Israel: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Advanced Therapy Medicinal Products CDMO Market - South Africa
      • 8.6.7.1. South Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Advanced Therapy Medicinal Products CDMO Market - Latin America
    • 8.7.1. Latin America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Advanced Therapy Medicinal Products CDMO Market - Mexico
      • 8.7.4.1. Mexico: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Advanced Therapy Medicinal Products CDMO Market - Brazil
      • 8.7.5.1. Brazil: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Advanced Therapy Medicinal Products CDMO Market - Argentina
      • 8.7.6.1. Argentina: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AGC Biologics (Switzerland)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bio Elpida (France)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BlueReg (France)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Catalent (US)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Celonic (Switzerland)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. CGT Catapult (UK)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Lonza (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Medicine Patheon (US)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Minaris Regenerative (US)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Rentschler Biopharma SE (US)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. WuXi Advanced Therapies (US)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables

  • Table 1 Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 2 Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 4 Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 6 North America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 8 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 9 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 11 Canada: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 12 Canada: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 14 Europe: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 15 Europe: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 17 UK: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 18 UK: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 20 France: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 21 France: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 23 Germany: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 24 Germany: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 26 Italy: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 27 Italy: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 29 Spain: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 30 Spain: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 35 Russia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 36 Russia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 41 China: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 42 China: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 44 India: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 India: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 50 Japan: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 51 Japan: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 56 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 57 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 65 UAE: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 66 UAE: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 68 Israel: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 69 Israel: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 71 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 72 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 74 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 75 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 77 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 78 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 80 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 81 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
  • Table 83 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
  • Table 84 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Advanced Therapy Medicinal Products CDMO Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Indication
  • Figure 9. Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Phase
  • Figure 11. Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2022 & 2032 (USD Billion)
  • Figure 12. Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Advanced Therapy Medicinal Products CDMO Market